89-005-604

interferon, gamma, Mouse, Polyclonal Antibody, Abnova™

Manufacturer: Abnova Corporation

Select a Size

Pack Size SKU Availability Price
Each of 1 89-005-604-Each-of-1 In Stock ₹ 42,898.00

89-005-604 - Each of 1

₹ 42,898.00

In Stock

Quantity

1

Base Price: ₹ 42,898.00

GST (18%): ₹ 7,721.64

Total Price: ₹ 50,619.64

Antigen

interferon, gamma

Classification

Polyclonal

Description

Mouse polyclonal antibody raised against a full-length human IFNG protein.

Gene

IFNG

Gene Alias

IFG/IFI

Host Species

Mouse

Quantity

50 μL

Research Discipline

Cytokines

Primary or Secondary

Primary

Target Species

Human

Form

Serum

Applications

Western Blot

Conjugate

Unconjugated

Formulation

No additive

Gene Accession No.

NM_000619

Gene Symbols

IFNG

Immunogen

IFNG (NP_000610, 1 a.a. ∼ 166 a.a) full-length human protein.

Regulatory Status

RUO

Whole Molecule

Yes

Gene ID (Entrez)

3458

Content And Storage

Store at -20°C or lower. Aliquot to avoid repeated freezing and thawing.

Related Products

Img

Abnova Corporation

89-005-595

--

Img

Abnova Corporation

89-005-693

--

Img

Abnova Corporation

89-005-414

--

Img

Abnova Corporation

89-005-374

--

Img

Abnova Corporation

89-007-753

--

Img

Abnova Corporation

89-007-859

--

Img

Abnova Corporation

89-005-193

--

Img

Abnova Corporation

89-005-156

--

Description

  • Interferon-gamma (IFNG), or type II interferon, is a cytokine critical for innate and adaptive immunity against viral and intracellular bacterial infections and for tumor control
  • Aberrant IFNG expression is associated with a number of autoinflammatory and autoimmune diseases
  • The importance of IFNG in the immune system stems in part from its ability to inhibit viral replication directly, but most importantly derives from its immunostimulatory and immunomodulatory effects
  • IFNG is produced predominantly by natural killer (NK) and natural killer T (NKT) cells as part of the innate immune response, and by CD4 (MIM 186940) and CD8 (see MIM 186910) cytotoxic T lymphocyte (CTL) effector T cells once antigen-specific immunity develops (Schoenborn and Wilson, 2007 [PubMed 17981204]).[supplied by OMIM Sequence: MKYTSYILAFQLCIVLGSLGCYCQDPYVKEAENLKKYFNAGHSDVADNGTLFLGILKNWKEESDRKIMQSQIVSFYFKLFKNFKDDQSIQKSVETIKEDMNVKFFNSNKKKRDDFEKLTNYSVTDLNVQRKAIHELIQVMAELSPAAKTGKRKRSQMLFQGRRASQ